RxSight Inc (RXST)

51.26 +0.16 (+0.32%) USD  |  NASDAQ  |  Nov 04, 16:00
51.26 0.00 (0.00%) After-Hours: 20:00
More

RxSight EPS Diluted (Quarterly): -0.16 for June 30, 2024

EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2020. Upgrade now.
Date Value
June 30, 2024 -0.16
March 31, 2024 -0.25
December 31, 2023 -0.25
September 30, 2023 -0.35
June 30, 2023 -0.40
March 31, 2023 -0.42
December 31, 2022 -0.56
September 30, 2022 -0.61
June 30, 2022 -0.61
Date Value
March 31, 2022 -0.64
December 31, 2021 -0.58
September 30, 2021 -0.68
June 30, 2021 -0.5125
March 31, 2021 -0.3568
December 31, 2020 0.9573
September 30, 2020 0.3093
June 30, 2020 -0.8902
March 31, 2020 -1.088

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (Quarterly) Range, Past 5 Years

-1.088
Minimum
Mar 2020
0.9573
Maximum
Dec 2020
-0.3939
Average
-0.4663
Median

EPS Diluted (Quarterly) Benchmarks

Tandem Diabetes Care Inc -0.47
Twist Bioscience Corp -1.47
Perspective Therapeutics Inc -0.18
Xtant Medical Holdings Inc -0.03
Catheter Precision Inc -5.57

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -6.079M
Revenue (Quarterly) 34.89M
Total Expenses (Quarterly) 43.22M
Enterprise Value 1.795B
Gross Profit Margin (Quarterly) 69.51%
Profit Margin (Quarterly) -17.42%
Earnings Yield -1.97%
Normalized Earnings Yield -1.909